|
|
|
Insider
Information: |
Mason Michael |
Relationship: |
|
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
398,667 |
|
Indirect Shares
|
276 |
|
|
Direct
Value |
$471,371 |
|
|
Indirect Value
|
$41,207 |
|
|
Total
Shares |
398,943 |
|
|
Total
Value |
$512,578 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
14
|
Stock
price went up :
|
0
|
1
|
Stock
price went down : |
0
|
13
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
-606.6%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Alnylam Pharmaceuticals Inc |
ALNY |
VP, Finance and Treasu... |
2018-08-13 |
563 |
2018-07-10 |
276 |
Premium* |
|
Karyopharm Therapeutics Inc. |
KPTI |
|
2024-06-04 |
398,104 |
2021-02-05 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
57 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ALNY |
Alnylam Pharmaceuticals I... |
VP, Finance and TreasurerOffic |
|
2011-02-28 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
708 |
|
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
VP, Finance and Treasurer |
|
2012-01-23 |
4 |
A |
$0.00 |
$0 |
D/D |
7,847 |
7,847 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
VP, Finance and Treasurer |
|
2017-12-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,502 |
8,502 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
VP, Finance and Treasurer |
|
2018-01-17 |
4 |
A |
$0.00 |
$0 |
I/I |
5 |
231 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
VP, Finance and Treasurer |
|
2018-04-16 |
4 |
A |
$0.00 |
$0 |
I/I |
22 |
253 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
VP, Finance and Treasurer |
|
2018-07-10 |
4 |
A |
$0.00 |
$0 |
I/I |
23 |
276 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
VP, Finance and Treasurer |
|
2018-08-13 |
4 |
A |
$0.00 |
$0 |
D/D |
1,012 |
1,012 |
0 |
- |
|
KPTI |
Karyopharm Therapeutics I... |
SVP, CFO & Treasurer |
|
2021-02-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,150 |
8,150 |
0 |
- |
|
KPTI |
Karyopharm Therapeutics I... |
SVP, CFO & Treasurer |
|
2021-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
22,013 |
51,755 |
0 |
- |
|
KPTI |
Karyopharm Therapeutics I... |
EVP, CFO, Treasurer |
|
2021-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
5,500 |
57,255 |
0 |
- |
|
KPTI |
Karyopharm Therapeutics I... |
EVP, CFO & Treasurer |
|
2022-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
88,200 |
141,508 |
0 |
- |
|
KPTI |
Karyopharm Therapeutics I... |
EVP, CFO & Treasurer |
|
2022-08-31 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
168,509 |
0 |
- |
|
KPTI |
Karyopharm Therapeutics I... |
EVP, CFO & Treasurer |
|
2023-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
95,000 |
256,566 |
0 |
- |
|
KPTI |
Karyopharm Therapeutics I... |
EVP, CFO & Treasurer |
|
2024-01-24 |
4 |
A |
$0.00 |
$0 |
D/D |
13,333 |
251,150 |
0 |
- |
|
KPTI |
Karyopharm Therapeutics I... |
EVP, CFO & Treasurer |
|
2024-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
188,205 |
432,605 |
0 |
- |
|
KPTI |
Karyopharm Therapeutics I... |
EVP, CFO & Treasurer |
|
2024-06-04 |
4 |
S |
$0.99 |
$645 |
D/D |
(652) |
398,104 |
0 |
% |
|
KPTI |
Karyopharm Therapeutics I... |
EVP, CFO & Treasurer |
|
2024-02-29 |
4 |
S |
$1.17 |
$32,394 |
D/D |
(27,687) |
404,918 |
0 |
% |
|
KPTI |
Karyopharm Therapeutics I... |
EVP, CFO & Treasurer |
|
2024-03-01 |
4 |
S |
$1.20 |
$7,394 |
D/D |
(6,162) |
398,756 |
0 |
% |
|
KPTI |
Karyopharm Therapeutics I... |
EVP, CFO & Treasurer |
|
2024-02-27 |
4 |
S |
$1.32 |
$3,369 |
D/D |
(2,545) |
244,400 |
0 |
% |
|
KPTI |
Karyopharm Therapeutics I... |
EVP, CFO & Treasurer |
|
2023-09-01 |
4 |
S |
$1.33 |
$9,203 |
D/D |
(6,913) |
237,817 |
0 |
% |
|
KPTI |
Karyopharm Therapeutics I... |
EVP, CFO & Treasurer |
|
2024-02-06 |
4 |
S |
$1.59 |
$6,671 |
D/D |
(4,205) |
246,945 |
0 |
% |
|
KPTI |
Karyopharm Therapeutics I... |
EVP, CFO & Treasurer |
|
2023-06-02 |
4 |
S |
$2.22 |
$1,401 |
D/D |
(631) |
244,730 |
0 |
% |
|
KPTI |
Karyopharm Therapeutics I... |
EVP, CFO & Treasurer |
|
2023-03-01 |
4 |
S |
$3.03 |
$33,942 |
D/D |
(11,205) |
245,361 |
0 |
% |
|
KPTI |
Karyopharm Therapeutics I... |
EVP, CFO & Treasurer |
|
2023-02-27 |
4 |
S |
$3.04 |
$8,509 |
D/D |
(2,802) |
161,566 |
0 |
% |
|
KPTI |
Karyopharm Therapeutics I... |
EVP, CFO & Treasurer |
|
2023-02-06 |
4 |
S |
$3.40 |
$14,079 |
D/D |
(4,141) |
164,368 |
0 |
% |
|
57 Records found
|
|
Page 1 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|